Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

Top-line results from PROSERA are expected in February 2026, according to Gossamer Bio, which is developing seralutinib in collaboration with the Chiesi Group as a treatment for PAH and pulmonary ...